CV Sciences (CVSI) Accounts Payables (2011 - 2026)
CV Sciences (CVSI) posted Accounts Payables of $1.1 million for Q1 2026, up 3.45% sequentially from $1.0 million in Q4 2025, and down 27.81% YoY from $1.5 million in Q1 2025.
CV Sciences (CVSI) Accounts Payables (2011 - 2026) Analysis & Trends
CV Sciences has reported Accounts Payables for 16 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Accounts Payables fell 27.81% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 27.81% YoY) and the FY2025 annual result came in at $1.0 million, down 45.77% from the prior year.
- Accounts Payables improved to $1.1 million in Q1 2026 per CVSI's latest filing, from $1.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $2.7 million in Q1 2022 and troughed at $1.0 million in Q4 2025.
- A 5-year average of $2.0 million and a median of $2.2 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables jumped 282.82% in 2022, then plunged 45.77% in 2025.
- Over 5 years, Accounts Payables stood at $2.3 million in 2022, then increased by 1.09% to $2.3 million in 2023, then slipped by 16.63% to $1.9 million in 2024, then slumped by 45.77% to $1.0 million in 2025, then grew by 3.45% to $1.1 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.1 million, $1.0 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.06 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 2.62 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 2.44 Mn |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | 2.25 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 2.62 Mn |
| Sep 30, 2021 | 1.51 Mn |